Helius Medical Technologies, Inc.

HSM on TSXToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
0.77CAN -0.05/-6.10%8,5550.35 / 2.9329.29 M
HSDT on NASDAQToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
0.57US -0.04/-7.23%621,4120.25 / 2.2121.68 M

Contact Information

Helius Medical Technologies, Inc.

Headquarters:
642 Newtown Yardley Rd., Suite 100
Newtown, Pennsylvania
USA, 18940
Tel: (877) 564-0008
Email: Send a message
Website: Visit website
For more information...
Lead: Steve Hosein

Helius Medical Technologies, Inc., (“Helius”), is a neurotech company in the medical device industry, focused on neurological wellness. Helius’ origin stems from the early 1990s, and the pioneering work in neuroplasticity at the Tactile Communication and Neurorehabilitation Laboratory, (“TCNL”), at the University of Wisconsin-Madison. This work led to the development of the investigational Portable Neuromodulation Stimulator (PoNSTM), delivering neurostimulation via the tongue which has been shown in clinical studies to improve the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. Sensing the enormous implications of addressing a massive unmet medical need, Helius was formed as a joint venture between the scientists (Yuri Danilov, Mitch Tyler, and Kurt Kaczmarek) and commercialization experts (Philippe Deschamps, Jonathan Sackier, and Montel Williams).

Phil Deschamps - President and Chief Executive Officer

Jonathan Sackier - Chief Medical Officer

Joyce LaViscount - Chief Financial Officer and Chief Operations Officer

Phil Deschamps - Chairman

Blane Walter - Director

Mitchell E. Tyler - Director

Huaizheng Peng, Ph D - Director

Edward M. Straw - Director

Thomas Griffin - Director

Jeffrey S. Mathiesen - Independent Director

Dane C. Andreeff - Director

Stock Information

Events

Aug 18, 2020 - 12:00 PM CDT Corporate Presentation - Minneapolis
Aug 19, 2020 - 12:00 PM CDT Corporate Presentation - Chicago
Aug 20, 2020 - 12:00 PM EDT Corporate Presentation - New York

Company Overview

Helius Medical Technologies, Inc., (“Helius”), is a neurotech company in the medical device industry, focused on neurological wellness. Helius’ origin stems from the early 1990s, and the pioneering work in neuroplasticity at the Tactile Communication and Neurorehabilitation Laboratory, (“TCNL”), at the University of Wisconsin-Madison. This work led to the development of the investigational Portable Neuromodulation Stimulator (PoNSTM), delivering neurostimulation via the tongue which has been shown in clinical studies to improve the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. Sensing the enormous implications of addressing a massive unmet medical need, Helius was formed as a joint venture between the scientists (Yuri Danilov, Mitch Tyler, and Kurt Kaczmarek) and commercialization experts (Philippe Deschamps, Jonathan Sackier, and Montel Williams).

Management

Phil Deschamps - President and Chief Executive Officer

Jonathan Sackier - Chief Medical Officer

Joyce LaViscount - Chief Financial Officer and Chief Operations Officer

Board of Directors

Phil Deschamps - Chairman

Blane Walter - Director

Mitchell E. Tyler - Director

Huaizheng Peng, Ph D - Director

Edward M. Straw - Director

Thomas Griffin - Director

Jeffrey S. Mathiesen - Independent Director

Dane C. Andreeff - Director

Contact Information

Headquarters:
642 Newtown Yardley Rd., Suite 100
Newtown, Pennsylvania
18940, USA
Telephone: (877) 564-0008
Email: Send a message
Website: Visit website